Here are relevant reports on : clinical-trial-recruitment-market
-
Enterprise AI Market by Component (Solution & Services), Technology, Application Area (Security & Risk, Marketing, Customer Support & Experience, HR & Recruitment, Process Automation), Deployment, Organization Size, Industry, & Region - Forecast to 2022
MarketsandMarkets expects the global enterprise Artificial Intelligence (AI) market to grow from USD 845.4 Million in 2017 to USD 6,141.5 Million by 2022, at a Compound Annual Growth Rate (CAGR) of 48.7% during the forecast period. The rising demand for AI-based solutions and platforms, and the need to analyze large and complex data sets are expected to drive the growth of the enterprise AI market. The enterprise AI market report encompasses the competitive landscape and company profiles of the key vendors based on their product offerings and business strategies. The major enterprise AI vendors include IBM (US), Microsoft (US), AWS (US), Intel (US), Google (US), SAP (Germany), Sentient Technologies (US), Oracle (US), HPE (US), and Wipro (India).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Home Healthcare Software - Product & Service Market - Application (Clinical, Non - Clinical), Usage (Laptop, Smartphone), Product (Agency, Clinical Management System, Telehealth, Hospice), Delivery (Web - Based, On - Premises, Cloud), End User - Global Forecast to 2018
The global home healthcare software and services market is estimated to reach $6.4 billion by 2018, at a CAGR of 13.4% between 2013 and 2018. The market will be driven by skyrocketing healthcare cost, spiralling aging population that increases the incidences of chronic disorders, hospital readmission reduction program by U.S., shortage of nursing and doctors staff, OASIS documentation, and favorable government initiatives.
- Published: May 2014
- Price: $ 4950
- TOC Available:
-
Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029
The global clinical trial imaging market, valued at US$1.32 billion in 2023, stood at US$1.42 billion in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$2.07 billion by the end of the period. The increase in R&D spending, growth in the pharmaceutical and biotechnology industry and the increasing number of CROs are driving the clinical trial imaging market.
- Published: October 2024
- Price: $ 4950
- TOC Available:
-
Biosimulation Market by Phase (Drug Discovery, Preclinical, Regulatory), Modality (Antibody, Peptide), Application (Molecular Design, PK/PD, QSP, Trial Simulation, Disease Modeling), Indication (Cardio, Onco), End User (CRO, Pharma) – Global Forecast to 2031
The global biosimulation market is projected to reach USD 9.24 billion by 2031, growing at a CAGR of 16.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Electronic Trial Master File (eTMF) Systems Market by Offering (Integrated, Standalone), Function (Analytic, Compliance, Workflow, Audit), Therapeutic (Onco, Cardio, Neuro), End User (Pharma, Biotech, MedDevice), Phase, Region - Global Forecast to 2030
The global electronic trial master file (eTMF) systems market, valued at US$1.21 billion in 2024, stood at US$1.36 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2024 to 2030, culminating in a forecasted valuation of US$2.49 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Europe eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (Pharma, Biotech, Medtech), Opportunities, Trends, Market Share - Forecast to 2030
The Europe eClinical solutions market, valued at US$2.82 billion in 2024, stood at US$3.18 billion in 2025 and is projected to advance at a resilient CAGR of 13.0% from 2025 to 2030, culminating in a forecasted valuation of US$5.86 billion by the end of the period. This growth is driven by the increasing shift toward digital and decentralized clinical trial models enabled by CTR and CTIS adoption.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Predictive Clinical Biomarkers Market by Product & Service (Consumable, Software), Technology (NGS, PCR), Disease (Cancer, Infectious), Application (Clinical Diagnostics)-Forecast to 2030
The predictive clinical biomarkers market, valued at US$7.84 billion in 2024, stood at US$8.49 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$14.69 billion by the end of the period. he market for predictive clinical biomarkers is growing rapidly as the healthcare industry shifts toward personalized and predictive medicine.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Europe Companion Animal Diagnostics Market by Product (Consumables, Instruments), Technology (Clinical Biochemistry, Molecular Diagnostics), Application (Clinical Pathology, Virology, Hematology), Animal (Dogs, Cats), End User - Forecast to 2031
The Europe companion animal diagnostics market, valued at USD0.43 billion in 2025, stood at USD0.46 billion in 2026 and is projected to advance at a resilient CAGR of 8.6% from 2026 to 2031, culminating in a forecasted valuation of USD0.70 billion by the end of the period. The market for diagnostics of companion animals in Europe is experiencing fast growth owing to factors such as increased pet ownership, animal health awareness, and advanced veterinary care being more widely accepted and costly.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
World Healthcare IT (Provider and Payor) Market - Clinical (EMR, PACS, RIS, CPOE, LIS) & Non-Clinical (RCM, Billing, Claims) Information systems Trends, opportunities & Forecast till 2015
The world healthcare IT market is expected to grow from $99.6 billion in 2010 to $162.2 billion in 2015, at a CAGR of 10.2% from 2010 to 2015. Need to cut healthcare costs, enhance clinical/administrative workflow of hospitals, and huge demand for faster, error-free, efficient healthcare delivery, is fueling the healthcare provider IT market worldwide. Furthermore, the initiatives taken by the government for adoption of healthcare IT systems globally are also a significant driving force. Some of the major initiatives expected to hugely impact the market are the U.S Healthcare reforms and ARRA incentives.
- Published: August 2011
- Price: $ 4950
- TOC Available:
-
Endocrine Testing Market by Type (Thyroid, Insulin, HCG, Prolactin, Progesterone, LH, FSH), Technology (Immunoassay, Tandem Mass Spectroscopy, Clinical Chemistry), End User (Hospitals, Clinical Laboratories) - Global Forecast to 2027
The global Endocrine Testing Market is expected to reach USD xx billion by 2027 from USD xx billion in 2022, at a CAGR of xx%. The growth in this market is driven by the increasing prevalence of the endocrine disorders such as thyroid imbalance, diabetes, Polycystic Ovary Syndrome, etc. Also, the increasing government funding and rising awareness for the endocrine hormone tests for the diagnosis and management of the endocrine disorder have also fueled the growth of the market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
